Gemcitabine in Treating Patients With Advanced Salivary Gland Cancer That Cannot Be Removed During Surgery
Status:
Completed
Trial end date:
2004-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to see how patients with incurable salivary gland cancer, who
have not had chemotherapy before, respond to Gemcitabine. The investigators are trying to
find out what effects (good and bad) Gemcitabine has on participants and salivary gland
cancer.
Gemcitabine has been shown to be an effective chemotherapy agent in other types of cancer,
including; bladder cancer, breast cancer, certain types of lung cancer, ovarian cancer, and
pancreas cancer. Gemcitabine has yet to be studied for efficacy in subjects with salivary
gland cancer and in general other chemotherapy drugs have shown to be ineffective so far in
this population.